Zobrazeno 1 - 10
of 760
pro vyhledávání: '"Leys K"'
Autor:
Stroe MS; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium., De Clerck L; ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium., Dhaenens M; ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium., Dennis RS; ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium., Deforce D; ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium., Carpentier S; Facility for Systems Biology Mass Spectrometry, KU Leuven, Leuven, Belgium., Annaert P; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; BioNotus GCV, Niel, Belgium., Leys K; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Smits A; Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Allegaert K; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands., Van Ginneken C; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium., Van Cruchten S; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium.
Publikováno v:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2024 Nov; Vol. 135 (5), pp. 620-640. Date of Electronic Publication: 2024 Sep 24.
Autor:
Stroe MS; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Huang MC; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Annaert P; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Leys K; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Smits A; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Allegaert K; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Van Bockstal L; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Valenzuela A; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Ayuso M; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Van Ginneken C; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.)., Van Cruchten S; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium (M.S.-S., L.V.B., A.V., M.A., C.V.G., S.V.C.); Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium (M.-C.H., P.A., K.L.); BioNotus GCV, Niel, Belgium (P.A.); Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium (A.S.); Departments of Development and Regeneration (A.S., K.A.) and Pharmaceutical and Pharmacological Sciences (K.A.), KU Leuven, Leuven, Belgium; and Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands (K.A.) steven.vancruchten@uantwerpen.be.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Jul 16; Vol. 52 (8), pp. 824-835. Date of Electronic Publication: 2024 Jul 16.
Autor:
Ozbey AC; Roche Pharma Research and Early Development, F.Hoffmann-La Roche, Switzerland neil_john.parrott@roche.com., Fowler S; Drug Metabolism, F. Hoffmann-La Roche Ltd, Switzerland., Leys K; Drug Delivery and Disposition Lab, Department of Pharmaceutical and Pharmacological, KU Leuven University, Belgium., Annaert P; Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium., Umehara K; Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development, Switzerland., Parrott N; Roche, Switzerland neil_john.parrott@roche.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2023 Oct 25. Date of Electronic Publication: 2023 Oct 25.
Autor:
Leys K; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences KU Leuven, Leuven, Belgium., Stroe MS; Comparative Perinatal Development, Department of Veterinary Sciences, University of Antwerp, Antwerp, Belgium., Annaert P; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences KU Leuven, Leuven, Belgium.; BioNotus GCV, Niel, Belgium., Van Cruchten S; Comparative Perinatal Development, Department of Veterinary Sciences, University of Antwerp, Antwerp, Belgium., Carpentier S; Facility for SYstems BIOlogy Mass Spectrometry, KU Leuven, Leuven, Belgium., Allegaert K; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Department of Hospital Pharmacy, Erasmus MC, GA, Rotterdam, The Netherlands.; Child and Youth Institute, KU Leuven, Leuven, Belgium., Smits A; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Child and Youth Institute, KU Leuven, Leuven, Belgium.; Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
Publikováno v:
Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2023 Jul-Dec; Vol. 19 (7), pp. 461-477. Date of Electronic Publication: 2023 Jul 28.
Autor:
Stroe MS; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium., Van Bockstal L; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium., Valenzuela A; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium., Ayuso M; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium., Leys K; Drug Delivery and Disposition, KU Leuven, Leuven, Belgium., Annaert P; Drug Delivery and Disposition, KU Leuven, Leuven, Belgium.; BioNotus GCV, Niel, Belgium., Carpentier S; Facility for Systems Biology Mass Spectrometry, KU Leuven, Leuven, Belgium., Smits A; Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Allegaert K; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Netherlands., Zeltner A; Göttingen Minipigs A/S, Dalmose, Denmark., Mulder A; Neonatal Intensive Care Unit, Antwerp University Hospital, Antwerp, Belgium., Van Ginneken C; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium., Van Cruchten S; Comparative Perinatal Development, University of Antwerp, Antwerp, Belgium.
Publikováno v:
Frontiers in pediatrics [Front Pediatr] 2023 May 04; Vol. 11, pp. 1163100. Date of Electronic Publication: 2023 May 04 (Print Publication: 2023).
Autor:
Leys, K
The Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of impaired neuromuscular transmission. It is associated with small cell lung carcinoma (SCLC) in 60% of patients. There is considerable evidence that the defect in LEMS is caused
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::29684b1a87d2d172809cd3b86e87683a
https://ora.ox.ac.uk/objects/uuid:f8a39d64-6491-45ea-91a3-71f3f969fd07
https://ora.ox.ac.uk/objects/uuid:f8a39d64-6491-45ea-91a3-71f3f969fd07
Autor:
Rahimi, Shoeleh1,2 (AUTHOR), Khankeh, Hamid Reza3 (AUTHOR) ha.khankeh@uswr.ac.ir, Ebadi, Abbas4,5 (AUTHOR), Mohammadian, Batol6 (AUTHOR), Eghbali, Mohammad7 (AUTHOR), habibzadeh, Fatemeh8 (AUTHOR)
Publikováno v:
PLoS ONE. 7/10/2024, Vol. 19 Issue 7, p1-15. 15p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lingzhi Xie1,2,3, Yun Zhang1,2,3, Ruyue Zhang1,2,3, Haibo Cui1,2,3, Baodong Cui1,2,3, Wenyong Han1,2,3, Nanwei Wan1,2,3 nanweiwan@zmu.edu.cn, Zhi Li4, Yongzheng Chen1,2,3 yzchen@zmu.edu.cn
Publikováno v:
Green Synthesis & Catalysis. May2024, Vol. 5 Issue 2, p88-93. 6p.